August 14, 2020

The Niche

Knoepfler lab stem cell blog

Jan Nolta

4 min read

What’s new this week in terms of reads includes a stem cell/drug combo for diabetic wonderments healing, more documentation of patient harms from stem cell clinics, and a list of recommending papers. Adult stem cells/glaucoma drug combo promotes diabetic wound healing in mice From a team of my UC Davis School of Medicine colleagues led by Rivkah Isseroff, Jan Nolta, Athena Soulika, and Thomas Peavy we have in Stem Cells Translational Medicine this exciting new paper, Combination product of dermal matrix, human mesenchymal stem cells, …Read More

2 min read

With stem cells there’s always all kinds of developments and news every week or even every day. Here is an assortment in no particular order of some of the latest news including some across the spectrum including weird and sometimes stuff. The linked phrases are often the actual headlines of the media pieces. New CIRM Alpha Stem Cell Clinic offers HOPE for boys with deadly disease (article focused on our CIRM-funded Alpha Clinic here at UC Davis as part of our Stem Cell Program). Note …Read More

2 min read

Today’s piece is a stem cell movers and shakers post about individuals who have gotten awards, made moves, or otherwise made news recently. In some cases I’ve included relevant embedded tweets announcing the news. In case you’re wondering, the image at right is my attempt last year to make a graphic design that reflect both movers and shakers (the salt shaker). You can see my movers and shakers piece from mid-2017 here. I once met a scientist much earlier in my career who when …Read More

3 min read

Stem cell good news time…and more will be coming later this week. The stem cell and regenerative medicine world sometimes feels chaotic because so much is going on both on the positive and negative sides of things. There is a whirlwind of activity and developments, and a tendency sometimes within our arena to just avoid bad or complicated news. One mission of this blog is to try to cover the full spectrum of developments including difficult situations, but I also want to focus in …Read More